DEVINCENZI ROBERT THOMAS
Known title: DirectorCIK: 0001226186
DEVINCENZI ROBERT THOMAS's purchase track record
DEVINCENZI ROBERT THOMAS has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/21/2026 | UTI | $40K | pending | pending | — |
| 8/25/2026 | UTI | $44K | pending | pending | — |
| 8/10/2026 | UTI | $252K | pending | pending | — |
| 8/12/2025 | UTI | $254K | +12.3% | +2.0% | +7.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| UTI | ▲ Buy | Open Market | 1,000 | $20K | 9/28/2026 | View on chart |
| UTI | ▲ Buy | Open Market | 1,000 | $20K | 9/21/2026 | View on chart |
| UTI | ▲ Buy | Open Market | 1,000 | $22K | 8/27/2026 | View on chart |
| UTI | ▲ Buy | Open Market | 1,000 | $22K | 8/25/2026 | View on chart |
| UTI | ▲ Buy | Open Market | 1,000 | $26K | 8/12/2026 | View on chart |
| UTI | ▲ Buy | Open Market | 8,000 | $226K | 8/10/2026 | View on chart |
| UTI | ▲ Buy | Grant | 3,565 | $0 | 3/5/2026 | View on chart |
| UTI | ▲ Buy | Open Market | 505 | $13K | 8/12/2025 | View on chart |
| UTI | ▲ Buy | Open Market | 9,495 | $241K | 8/12/2025 | View on chart |
| UTI | ▲ Buy | Grant | 714 | $0 | 6/5/2025 | View on chart |
| UTI | ▲ Buy | Grant | 3,599 | $0 | 2/27/2025 | View on chart |
| UTI | ▼ Sell | Open Market | 6,086 | $158K | 11/25/2024 | View on chart |
| UTI | ▲ Buy | Option Exercise | 150,000 | $471K | 11/25/2024 | View on chart |
| UTI | ▼ Sell | Open Market | 143,914 | $3.7M | 11/25/2024 | View on chart |
| UTI | ▲ Buy | Grant | 6,789 | $0 | 2/28/2024 | View on chart |
| UTI | ▲ Buy | Grant | 9,895 | $0 | 2/22/2023 | View on chart |
| UTI | ▲ Buy | Grant | 8,772 | $0 | 2/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
UTI Cuts 2026 Outlook Amid Customer Acquisition Headwinds
Universal Technical Institute has lowered its 2026 financial outlook, citing rising challenges in acquiring new customers. This move prompts investors to reassess the company's valuation, particularly given its current trailing P/E of 32.8. While demand for skilled trades remains strong, these acquisition costs may impact future earnings growth.
UTI Cuts 2026 Outlook Amid Customer Acquisition Headwinds. Universal Technical Institute has lowered its 2026 financial outlook, citing rising challenges in acquiring new customers. This move prompts investors to reassess the company's valuation, particularly given its current trailing P/E of 32.8. While demand for skilled trades remains strong, these acquisition costs may impact future earnings growth.